These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24523409)

  • 1. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.
    Jehle K; Cato L; Neeb A; Muhle-Goll C; Jung N; Smith EW; Buzon V; Carbó LR; Estébanez-Perpiñá E; Schmitz K; Fruk L; Luy B; Chen Y; Cox MB; Bräse S; Brown M; Cato AC
    J Biol Chem; 2014 Mar; 289(13):8839-51. PubMed ID: 24523409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural features discriminate androgen receptor N/C terminal and coactivator interactions.
    Askew EB; Minges JT; Hnat AT; Wilson EM
    Mol Cell Endocrinol; 2012 Jan; 348(2):403-10. PubMed ID: 21664945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
    Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
    Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric conversation in the androgen receptor ligand-binding domain surfaces.
    Grosdidier S; Carbó LR; Buzón V; Brooke G; Nguyen P; Baxter JD; Bevan C; Webb P; Estébanez-Perpiñá E; Fernández-Recio J
    Mol Endocrinol; 2012 Jul; 26(7):1078-90. PubMed ID: 22653923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
    Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
    Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer.
    Cato L; Neeb A; Sharp A; Buzón V; Ficarro SB; Yang L; Muhle-Goll C; Kuznik NC; Riisnaes R; Nava Rodrigues D; Armant O; Gourain V; Adelmant G; Ntim EA; Westerling T; Dolling D; Rescigno P; Figueiredo I; Fauser F; Wu J; Rottenberg JT; Shatkina L; Ester C; Luy B; Puchta H; Troppmair J; Jung N; Bräse S; Strähle U; Marto JA; Nienhaus GU; Al-Lazikani B; Salvatella X; de Bono JS; Cato AC; Brown M
    Elife; 2017 Aug; 6():. PubMed ID: 28826504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conserved surface on the ligand binding domain of nuclear receptors for allosteric control.
    Buzón V; Carbó LR; Estruch SB; Fletterick RJ; Estébanez-Perpiñá E
    Mol Cell Endocrinol; 2012 Jan; 348(2):394-402. PubMed ID: 21878368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain interactions between coregulator ARA(70) and the androgen receptor (AR).
    Zhou ZX; He B; Hall SH; Wilson EM; French FS
    Mol Endocrinol; 2002 Feb; 16(2):287-300. PubMed ID: 11818501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
    Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
    Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone.
    Askew EB; Gampe RT; Stanley TB; Faggart JL; Wilson EM
    J Biol Chem; 2007 Aug; 282(35):25801-16. PubMed ID: 17591767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
    Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP
    Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptor.
    Shatkina L; Mink S; Rogatsch H; Klocker H; Langer G; Nestl A; Cato AC
    Mol Cell Biol; 2003 Oct; 23(20):7189-97. PubMed ID: 14517289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A surface on the androgen receptor that allosterically regulates coactivator binding.
    Estébanez-Perpiñá E; Arnold LA; Nguyen P; Rodrigues ED; Mar E; Bateman R; Pallai P; Shokat KM; Baxter JD; Guy RK; Webb P; Fletterick RJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16074-9. PubMed ID: 17911242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAG1L: a promising therapeutic target for androgen receptor-dependent prostate cancer.
    Lee II; Kuznik NC; Rottenberg JT; Brown M; Cato ACB
    J Mol Endocrinol; 2019 May; 62(4):R289-R299. PubMed ID: 30913537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.
    He B; Gampe RT; Kole AJ; Hnat AT; Stanley TB; An G; Stewart EL; Kalman RI; Minges JT; Wilson EM
    Mol Cell; 2004 Nov; 16(3):425-38. PubMed ID: 15525515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction.
    Bai S; He B; Wilson EM
    Mol Cell Biol; 2005 Feb; 25(4):1238-57. PubMed ID: 15684378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
    He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
    J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.
    Alen P; Claessens F; Verhoeven G; Rombauts W; Peeters B
    Mol Cell Biol; 1999 Sep; 19(9):6085-97. PubMed ID: 10454556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.
    Estébanez-Perpiñá E; Moore JM; Mar E; Delgado-Rodrigues E; Nguyen P; Baxter JD; Buehrer BM; Webb P; Fletterick RJ; Guy RK
    J Biol Chem; 2005 Mar; 280(9):8060-8. PubMed ID: 15563469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.